Monday, September 16, 2024 7:29:23 AM
Not as good as i was thinking yesterday, also looks like BMS is pulling out.
https://finance.yahoo.com/news/immatics-presents-clinical-proof-concept-092500575.html
Remember this was targetting mage, IMA402 was targetting prame, so there is still hope those results are better. Hope we get an update on IMA402 before year end. TCRX has had excellent success with leukemia targetting prame.
I have to admit today's news is not that good, imo
Recent IMTX News
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/05/2026 12:12:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:00:37 PM
- Immatics Announces Full Year 2025 Financial Results and Business Update • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 01:35:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/12/2026 09:09:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/11/2025 12:10:17 PM
- Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress • GlobeNewswire Inc. • 12/11/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/08/2025 09:20:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/05/2025 10:20:55 PM
- Immatics Announces $125 Million Underwritten Offering • GlobeNewswire Inc. • 12/05/2025 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2025 12:08:03 PM
- Immatics Announces Third Quarter 2025 Financial Results and Business Update • GlobeNewswire Inc. • 11/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/12/2025 12:19:29 PM
- Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps • GlobeNewswire Inc. • 11/12/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2025 11:05:06 AM
- Immatics Appoints Amie Krause as Chief People Officer • GlobeNewswire Inc. • 10/27/2025 11:00:00 AM
- Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium • GlobeNewswire Inc. • 10/20/2025 02:30:00 PM
- Immatics Appoints Venkat Ramanan as Chief Financial Officer • GlobeNewswire Inc. • 10/01/2025 11:00:00 AM
- Immatics Announces Second Quarter 2025 Financial Results and Business Update • GlobeNewswire Inc. • 08/13/2025 11:00:00 AM
- Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma • GlobeNewswire Inc. • 05/31/2025 12:00:00 PM
- Immatics Announces First Quarter 2025 Financial Results and Business Update • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting • GlobeNewswire Inc. • 04/23/2025 02:00:00 PM
- Immatics Announces Full Year 2024 Financial Results and Business Update • GlobeNewswire Inc. • 03/27/2025 11:00:00 AM
FEATURED C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
ECGI Highlights RezyFi Live Pilot Progress in CEO Interview Update • ECGI • Mar 3, 2026 8:30 AM
Journal of Analytical Toxicology Publishes Peer-Reviewed Validation Study • BLO • Mar 3, 2026 8:18 AM
LaFleur Minerals Announces Positive PEA Results for the Swanson Gold Deposit • LFLRF • Mar 3, 2026 8:00 AM
